-

City of Hope Chicago Honors Cancer Survivors at Annual Celebrate Life Event

The event celebrated the life and survivorship of nearly 300 City of Hope Chicago patients

CHICAGO--(BUSINESS WIRE)--City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. and ranked among the nation’s top 5 cancer centers by U.S. News & World Report, honored the growing number of cancer survivors who have received care at City of Hope Chicago and their powerful journeys to becoming cancer free at its annual Celebrate Life® event.

For more than three decades, Celebrate Life has existed as a way of honoring the strength, determination and spirit of survivors who entrust City of Hope with their care and providing connection among this inspiring community.

This year’s event honored nearly 300 cancer survivors, both in person and virtual, celebrating five or more years since they began treatment at City of Hope Chicago, as well as the caregivers who have supported them. This important milestone was commemorated by their inclusion on the City of Hope Survivor Tree — a symbol of strength and inspiration.

“Celebrate Life embodies the steadfast spirit and determination of our survivors and serves as a poignant reminder of our commitment to our patients, our purpose and the culture of compassion that defines us — at our Chicago cancer center and beyond,” said Pete Govorchin, M.B.A., president, City of Hope Chicago. “Their resilience and courage is a beacon of hope for those grappling with cancer, and it is our greatest honor to be a part of their stories.”

For more information about Celebrate Life, visit cityofhope.org/patients/celebrate-life-2024.

About City of Hope

City of Hope's mission is to make hope a reality for all touched by cancer and diabetes. Founded in 1913, City of Hope has grown into one of the largest and most advanced cancer research and treatment organizations in the U.S., and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center that is ranked top 5 in the nation for cancer care by U.S. News & World Report at its core, City of Hope’s uniquely integrated model spans cancer care, research and development, academics and training, and a broad philanthropy program that powers its work. City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and cancer treatment centers and outpatient facilities in the Atlanta, Chicago and Phoenix areas. City of Hope’s affiliated group of organizations includes Translational Genomics Research Institute and AccessHopeTM. For more information about City of Hope, follow us on Facebook, X, YouTube, Instagram and LinkedIn.

Contacts

Cathy Ingram
847-731-1520
cathryn.ingram@coh.org

City of Hope


Release Versions

Contacts

Cathy Ingram
847-731-1520
cathryn.ingram@coh.org

More News From City of Hope

Study Reveals How Gut Bacteria and Diet Can Reprogram Fat to Burn More Energy

LOS ANGELES--(BUSINESS WIRE)--Scientists at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. and a leading research center for diabetes, the Broad Institute and Keio University have discovered how specific gut bacteria work together with diet to flip a metabolic switch — transforming energy‑storing white fat into calorie‑burning beige fat in mice. The study, published today in Nature, shows that a low‑protein diet activates a precise se...

City of Hope®: Early Diagnostics Will Stem the Surge of Colorectal Cancer in Younger Adults

LOS ANGELES--(BUSINESS WIRE)--Experts at City of Hope, one of the nation’s largest and most advanced cancer research and treatment organizations, say the surge in colorectal cancer in people under 50 — often compounded by delayed diagnoses and misinterpreted symptoms — requires age-specific research, treatments, education, and diagnostic tools. A blood test under development at City of Hope could become a breakthrough for detecting the disease early, making it part of an annual exam. Colorectal...

Second Annual $1 Million Stephenson Global Prize Now Open for Nominations

LOS ANGELES--(BUSINESS WIRE)--The Stephenson Global Prize, a $1 million award for innovation in pancreatic cancer research, has opened its second call for nominations. Awarded annually, the Prize recognizes visionary scientific leaders whose work is fundamentally changing the trajectory of pancreatic cancer research. Nominations are now open through May 1, 2026. The Stephenson Global Prize is part of a philanthropic program launched by A. Emmet Stephenson Jr., and Tessa Stephenson Brand. Their...
Back to Newsroom